Ascendis Pharma A/S Current Ratio for the Trailing 12 Months (TTM) ending March 31, 2025: 1.03

Ascendis Pharma A/S Current Ratio is 1.03 for the Trailing 12 Months (TTM) ending March 31, 2025, a -48.14% change year over year. Current ratio represents the short-term liquidity measurement, showing current assets' coverage of liabilities. Higher ratio implies better ability to meet short-term obligations.
  • Ascendis Pharma A/S Current Ratio for the Trailing 12 Months (TTM) ending March 31, 2024 was 1.99, a -68.02% change year over year.
  • Ascendis Pharma A/S Current Ratio for the Trailing 12 Months (TTM) ending March 31, 2023 was 6.21, a -31.39% change year over year.
  • Ascendis Pharma A/S Current Ratio for the Trailing 12 Months (TTM) ending March 31, 2022 was 9.05, a -23.29% change year over year.
  • Ascendis Pharma A/S Current Ratio for the Trailing 12 Months (TTM) ending March 31, 2021 was 11.79, a -10.09% change year over year.
Key Data
Date Current Ratio Interest Coverage Ratio Return on Capital Employed (ROCE) Return on Equity (ROE)